Longeveron Inc - Class A — Cash Flow (NASDAQ:LGVN) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities 9.64 M13.97 M19 M13.87 M 16.72 M Cash from investing activities 10.7 M677 K8.19 M640 K 654 K Cash from financing activities 45.17 M509 K5.26 M28.79 M 3.84 M Free cash flow 8.33 M13.11 M18.31 M12.88 M 16.07 M

Haberler

Longeveron 15 milyon dolarlık finansman kapattı

Longeveron closes $15 million financing, extends runway to 4Q26

Longeveron 15 milyon dolar finansman sağladı

Longeveron secures $15M financing, eyes $15M more on trial results

Longeveron faz 2b kök hücre deney sonuçlarını yayınladı

Longeveron publishes phase 2b stem cell trial results in journal

Longeveron, önemli deneme sonuçları öncesinde Stephen Willard’ı yeni CEO olarak atadı

Longeveron appoints Stephen Willard as new CEO ahead of pivotal trial results

Longeveron receives Japanese patent for stem cell potency assay methods

Longeveron prepares for pivotal HLHS therapy data with FDA meeting

Longeveron receives patent for stem cell therapy targeting female sexual dysfunction

Longeveron yöneticileri CVCT Forumu’nda hücre tedavisi denemeleri hakkında konuşacak